-
Product Insights
Likelihood of Approval Analysis for Malaria
Overview How likely is it that the drugs in Malaria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malaria Overview Malaria is a life-threatening blood disease caused by a parasite (Plasmodium)...
-
Product Insights
Likelihood of Approval Analysis for Post Menopausal Osteoporosis
Overview How likely is it that the drugs in Post Menopausal Osteoporosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post Menopausal Osteoporosis Overview Postmenopausal osteoporosis is the most common form...
-
Product Insights
Likelihood of Approval Analysis for Cervical Intraepithelial Neoplasia (CIN)
Overview How likely is it that the drugs in Cervical Intraepithelial Neoplasia (CIN) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cervical Intraepithelial Neoplasia (CIN) Overview Cervical intraepithelial neoplasia (CIN), also...
-
Product Insights
Likelihood of Approval Analysis for Neisseria Infections
Overview How likely is it that the drugs in Neisseria Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neisseria Infections Overview Meningococcal disease refers to any illness caused by bacteria...
-
Product Insights
Likelihood of Approval Analysis for Urinary Tract Infections
Overview How likely is it that the drugs in Urinary Tract Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Urinary Tract Infections Overview A urinary tract infection (UTI) is a...
-
Product Insights
Likelihood of Approval Analysis for Squamous Non-Small Cell Lung Carcinoma
Overview How likely is it that the drugs in Squamous Non-Small Cell Lung Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Squamous Non-Small Cell Lung Carcinoma Overview Squamous cell carcinoma...
-
Product Insights
Likelihood of Approval Analysis for Genital Warts (Condylomata Acuminata)
Overview How likely is it that the drugs in Genital Warts (Condylomata Acuminata) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Genital Warts (Condylomata Acuminata) Overview Genital warts (condyloma acuminatum) are...
-
Product Insights
Likelihood of Approval Analysis for Menopausal Disorders
Overview How likely is it that the drugs in Menopausal Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Menopausal Disorders Overview Menopausal disorders encompass a range of symptoms and health...
-
Product Insights
Likelihood of Approval Analysis for Post Partum Depression (Maternal Depression / Postnatal Depression)
Overview How likely is it that the drugs in Post Partum Depression (Maternal Depression / Postnatal Depression) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post Partum Depression (Maternal Depression /...
-
Product Insights
Likelihood of Approval Analysis for Primary Progressive Multiple Sclerosis (PPMS)
Overview How likely is it that the drugs in Primary Progressive Multiple Sclerosis (PPMS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Primary Progressive Multiple Sclerosis (PPMS) Overview Primary progressive multiple...